| Financial Year |
March 31 2023 |
| Monetary Funds |
251,623,962.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
11,276,379.12 |
| Advances to Suppliers |
13,444,859.30 |
| Other Receivables |
12,430,156.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
19,445,088.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,326,383.55 |
| Total Current Assets |
309,546,828.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,054,324.83 |
| Investment Properties |
8,102,022.55 |
| Fixed Assetes |
563,009,303.38 |
| Under-construction Projects |
23,559,019.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,064,640.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,500.00 |
| Deferred Income Tax Assets |
3,257,493.28 |
| Other Non-Current Assets |
402,144.00 |
| Sub-Total of Non-Current Assets |
673,734,679.72 |
| Total Assets |
983,281,508.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,279,304.72 |
| Accounts Received In Advance |
51,500.00 |
| Employee Compensation Payable |
21,079,456.60 |
| Taxes Payable |
30,261,577.05 |
| Interest Payable |
30,325,432.28 |
| Dividend Payable |
-- |
| Other payables |
142,080,427.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
147,366,389.21 |
| Other Current Liabilities |
1,907,991.98 |
| Sub-Total of Current Liabilities |
385,226,558.23 |
| Long-term Loans |
124,826,100.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
211,341,550.89 |
| Deferred Income Tax Liabilities |
5,012,260.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
342,955,246.81 |
| Total Liabilities |
728,181,805.04 |
| Paid-In Capital(Or Share Stock) |
752,328,267.00 |
| Capital Surplus |
620,627,597.70 |
| Surplus Reserve |
30,864,384.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,172,260,209.84 |
| Minority Stockholder's Interest |
7,077,347.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
248,022,356.53 |
| Owner's Equity（Stockholder's Equity） |
255,099,703.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
983,281,508.63 |
